Kissei is seeking collaborations
Kissei Pharmaceutical business development
Kissei Pharmaceutical Co., Ltd. believes that R&D is fundamental to the operations of a pharmaceutical company, and that belief forms the foundation of their aggressive approach to R&D.
In addition to their commitment to being an R&D-oriented pharmaceutical company that provides high-quality, innovative pharmaceutical products, they actively seek licensing opportunities to tie up with other pharmaceutical companies and bio-ventures around the world.
Through such collaborative arrangements, they offer various innovative medicines that are clinically used in the treatment of many patients, including Bezatol®, an agent for hyperlipidemia (licensed from Roche); Cabasar®, an agent for Parkinson's disease (licensed from Pfizer).
Based on their licensing policy, they are widely accepting new ideas and technologies for the development of new medicines. You are invited to submit a non-confidential scientific overview of your ideas or technologies for their scientific review by submitting an offer online.
Their R&D activities focus on the
- urogenital system
- metabolism and endocrinology
- immunology and allergies.